학술논문
Extended pleurectomy decortication and chemotherapy versus chemotherapy alone for pleural mesothelioma (MARS 2): a phase 3 randomised controlled trial
Document Type
Article
Author
Lim, Eric; Waller, David; Lau, Kelvin; Steele, Jeremy; Pope, Anthony; Ali, Clinton; Bilancia, Rocco; Keni, Manjusha; Popat, Sanjay; O'Brien, Mary; Tokaca, Nadza; Maskell, Nick; Stadon, Louise; Fennell, Dean; Nelson, Louise; Edwards, John; Tenconi, Sara; Socci, Laura; Rintoul, Robert C; Wood, Kelly; Stone, Amanda; Muthukumar, Dakshinamoorthy; Ingle, Charlotte; Taylor, Paul; Cove-Smith, Laura; Califano, Raffaele; Summers, Yvonne; Tasigiannopoulos, Zacharias; Bille, Andrea; Shah, Riyaz; Fuller, Elizabeth; Macnair, Andrew; Shamash, Jonathan; Mansy, Talal; Milton, Richard; Koh, Pek; Ionescu, Andreea Alina; Treece, Sarah; Roy, Amy; Middleton, Gary; Kirk, Alan; Harris, Rosie A; Ashton, Kate; Warnes, Barbara; Bridgeman, Emma; Joyce, Katherine; Mills, Nicola; Elliott, Daisy; Farrar, Nicola; Stokes, Elizabeth; Hughes, Vikki; Nicholson, Andrew G; Rogers, Chris A
Source
The Lancet Respiratory Medicine; June 2024, Vol. 12 Issue: 6 p457-466, 10p
Subject
Language
ISSN
22132600; 22132619
Abstract
Extended pleurectomy decortication for complete macroscopic resection for pleural mesothelioma has never been evaluated in a randomised trial. The aim of this study was to compare outcomes after extended pleurectomy decortication plus chemotherapy versus chemotherapy alone.